Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_2
4
67%
Ph phase_3
2
33%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
4(66.7%)
Phase 3Large-scale testing
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Other(2)

Detailed Status

Active, not recruiting2
Completed2
unknown1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (66.7%)
Phase 32 (33.3%)

Trials by Status

active_not_recruiting233%
completed233%
unknown117%
suspended117%

Recent Activity

2 active trials
Showing 5 of 6
active_not_recruitingphase_2

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

NCT05690503
suspendedphase_3

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

NCT03344419
active_not_recruitingphase_3

Facilitating Rapid Naltrexone Initiation

NCT03345173
unknownphase_2

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

NCT04084860
completedphase_2

Glutamatergic Modulation of Disordered Alcohol Use

NCT02539511
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05690503Phase 2

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Active Not Recruiting
NCT03344419Phase 3

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Suspended
NCT03345173Phase 3

Facilitating Rapid Naltrexone Initiation

Active Not Recruiting
NCT04084860Phase 2

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

Unknown
NCT02539511Phase 2

Glutamatergic Modulation of Disordered Alcohol Use

Completed
NCT02596022Phase 2

The Effect of Glutamatergic Modulation on Cocaine Self-administration

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6